0001012975-19-000251.txt : 20190327
0001012975-19-000251.hdr.sgml : 20190327
20190327181702
ACCESSION NUMBER: 0001012975-19-000251
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190327
FILED AS OF DATE: 20190327
DATE AS OF CHANGE: 20190327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic Fund, L.P.
CENTRAL INDEX KEY: 0001504130
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 19709355
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-522-0100
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic GP, L.P.
CENTRAL INDEX KEY: 0001770834
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 19709356
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-800-0800
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic GP, Ltd.
CENTRAL INDEX KEY: 0001770835
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 19709357
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-800-0800
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adelman Robert J
CENTRAL INDEX KEY: 0001329161
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 19709358
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOODMAN COREY S
CENTRAL INDEX KEY: 0001278411
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 19709359
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRECISION BIOSCIENCES INC
CENTRAL INDEX KEY: 0001357874
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
BUSINESS PHONE: 919-314-5512
MAIL ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
3
1
edgar.xml
PRIMARY DOCUMENT
X0206
3
2019-03-27
0
0001357874
PRECISION BIOSCIENCES INC
DTIL
0001504130
venBio Global Strategic Fund, L.P.
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
1
0
1
0
0001770834
venBio Global Strategic GP, L.P.
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
0
0
1
0
0001770835
venBio Global Strategic GP, Ltd.
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
0
0
1
0
0001329161
Adelman Robert J
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
1
0
1
0
0001278411
GOODMAN COREY S
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
0
0
1
0
Series A Preferred Stock
Common Stock
3747623
I
See footnote
Series B Preferred Stock
Common Stock
467518
I
See footnote
Each share of the Issuer's preferred stock is convertible, at any time, at the holder's election, into shares of the Issuer's common stock, $0.000005 par value per share (the "Common Stock"). Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock and Series B Preferred Stock will convert into shares of Common Stock on a one-for-2.134686 basis, after giving effect to the reverse stock split effected by the Issuer in connection with the initial public offering. Neither the Series A Preferred Stock nor the Series B Preferred Stock has an expiration date.
venBio Global Strategic GP, L.P. is the sole general partner of venBio Global Strategic Fund, L.P. and venBio Global Strategic GP, Ltd. is the sole general partner of venBio Global Strategic GP, L.P. Robert Adelman and Corey Goodman are directors of venBio Global Strategic GP, Ltd. Each of venBio Global Strategic GP, L.P., venBio Global Strategic GP, Ltd., Mr. Adelman and Mr. Goodman disclaims beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein.
venBio Global Strategic Fund, L.P., by: venBio Global Strategic GP, L.P., its general partner, by: venBio Global Strategic GP, Ltd., its general partner, by: /s/ David Pezeshki, Attorney-in-Fact
2019-03-27
venBio Global Strategic GP, L.P., by: venBio Global Strategic GP, Ltd., its general partner, by: /s/ David Pezeshki, Attorney-in-Fact
2019-03-27
venBio Global Strategic GP, Ltd., by: /s/ David Pezeshki, Attorney-in-Fact
2019-03-27
Robert Adelman, by: /s/ David Pezeshki, Attorney-in-Fact
2019-03-27
Corey Goodman, by: /s/ David Pezeshki, Attorney-in-Fact
2019-03-27